These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32410307)

  • 1. Reduction of surgical rates in inflammatory bowel diseases biologic era: Similarities between Spain and Latin America.
    Quaresma AB; Kotze PG
    J Gastroenterol Hepatol; 2020 Aug; 35(8):1453. PubMed ID: 32410307
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011-2014: A Nationwide Population-Based Study.
    Jung YS; Han M; Kim WH; Park S; Cheon JH
    Dig Dis Sci; 2017 Aug; 62(8):2102-2112. PubMed ID: 28593437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European Crohn's and Colitis Organisation Topical Review on IBD in the Elderly.
    Sturm A; Maaser C; Mendall M; Karagiannis D; Karatzas P; Ipenburg N; Sebastian S; Rizzello F; Limdi J; Katsanos K; Schmidt C; Jeuring S; Colombo F; Gionchetti P
    J Crohns Colitis; 2017 Mar; 11(3):263-273. PubMed ID: 27797918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BIOLOGICAL THERAPY PENETRATION FOR INFLAMMATORY BOWEL DISEASE IN LATIN AMERICA: CURRENT STATUS AND FUTURE CHALLENGES.
    Quaresma AB; Coy CSR; Damião AOMC; Kaplan GG; Kotze PG
    Arq Gastroenterol; 2019; 56(3):318-322. PubMed ID: 31633732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Anti-TNFα Agents and Time to First-time Surgery in Paediatric Patients with Ulcerative Colitis and Crohn's Disease.
    Larsen MD; Qvist N; Nielsen J; Kjeldsen J; Nielsen RG; Nørgård BM
    J Crohns Colitis; 2016 Jun; 10(6):650-6. PubMed ID: 26802081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should biologic agents be stopped before surgery for inflammatory bowel disease?
    Zaghiyan K; McGovern D; Fleshner P
    Expert Rev Gastroenterol Hepatol; 2015 Mar; 9(3):269-72. PubMed ID: 25366845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the need for inflammatory bowel disease surgery diminishing in the biologic era?
    Faiz O; Worley G
    Colorectal Dis; 2019 Mar; 21(3):259-260. PubMed ID: 30821915
    [No Abstract]   [Full Text] [Related]  

  • 8. Epidemiology and Long-term Outcome of Inflammatory Bowel Disease Diagnosed at Elderly Age-An Increasing Distinct Entity?
    Jeuring SF; van den Heuvel TR; Zeegers MP; Hameeteman WH; Romberg-Camps MJ; Oostenbrug LE; Masclee AA; Jonkers DM; Pierik MJ
    Inflamm Bowel Dis; 2016 Jun; 22(6):1425-34. PubMed ID: 26933752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change of treatment modalities over the last 10 years in pediatric patients with inflammatory bowel disease in Switzerland.
    Guilcher K; Fournier N; Schoepfer A; Schibli S; Spalinger J; Braegger C; Nydegger A;
    Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1159-1167. PubMed ID: 29985208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative Considerations in Inflammatory Bowel Disease.
    McKenna NP; Lightner AL
    Surg Clin North Am; 2019 Dec; 99(6):1083-1094. PubMed ID: 31676049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European Crohn's and Colitis Organisation Topical Review on Treatment Withdrawal ['Exit Strategies'] in Inflammatory Bowel Disease.
    Doherty G; Katsanos KH; Burisch J; Allez M; Papamichael K; Stallmach A; Mao R; Berset IP; Gisbert JP; Sebastian S; Kierkus J; Lopetuso L; Szymanska E; Louis E
    J Crohns Colitis; 2018 Jan; 12(1):17-31. PubMed ID: 28981623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between preoperative tumor necrosis factor alpha inhibitor and surgical site infection after surgery for inflammatory bowel disease: a systematic review and meta-analysis.
    Uchino M; Ikeuchi H; Shimizu J; Ohge H; Haji S; Mizuguchi T; Mohri Y; Yamashita C; Kitagawa Y; Suzuki K; Kobayashi M; Kobayashi M; Sakamoto F; Yoshida M; Mayumi T; Hirata K; Takesue Y
    Surg Today; 2021 Jan; 51(1):32-43. PubMed ID: 32277281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of intestinal complications in inflammatory bowel disease: a comparison between paediatric-onset and adult-onset patients.
    Herzog D; Fournier N; Buehr P; Rueger V; Koller R; Heyland K; Nydegger A; Braegger CP;
    Eur J Gastroenterol Hepatol; 2017 Aug; 29(8):926-931. PubMed ID: 28471820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis on the use of anti-tumor necrosis factor drugs in inflammatory bowel disease].
    Cabriada JL; Vera I; Domènech E; Barreiro-de Acosta M; Esteve M; Gisbert JP; Panés J; Gomollón F;
    Gastroenterol Hepatol; 2013 Mar; 36(3):127-46. PubMed ID: 23433780
    [No Abstract]   [Full Text] [Related]  

  • 15. 2019 Expert opinion on biological treatment use in inflammatory bowel disease management.
    Törüner M; Akpınar H; Akyüz F; Dağlı Ü; Över Hamzaoğlu H; Tezel A; Ünsal B; Yıldırım S; Çelik AF
    Turk J Gastroenterol; 2019 Nov; 30(Suppl 4):S913-S946. PubMed ID: 32207688
    [No Abstract]   [Full Text] [Related]  

  • 16. Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia.
    Ooi CJ; Hilmi I; Banerjee R; Chuah SW; Ng SC; Wei SC; Makharia GK; Pisespongsa P; Chen MH; Ran ZH; Ye BD; Park DI; Ling KL; Ong D; Ahuja V; Goh KL; Sollano J; Lim WC; Leung WK; Ali RAR; Wu DC; Ong E; Mustaffa N; Limsrivilai J; Hisamatsu T; Yang SK; Ouyang Q; Geary R; De Silva JH; Rerknimitr R; Simadibrata M; Abdullah M; Leong RWL;
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1296-1315. PubMed ID: 30848854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgery--indispensable complement ot drug therapy].
    Andersson MV; Andersson P; Bohe M; Börjesson L; Graf W; Jeppsson B; Törkvist L; Akerlund JE; Söderholm JD
    Lakartidningen; 2009 Nov 4-12; 106(45):3003-9. PubMed ID: 19998827
    [No Abstract]   [Full Text] [Related]  

  • 18. Decreasing major surgical rates for Crohn's disease in an emerging economy over two decades: Is it due to biologic therapy?
    Chuah KH; Raja Ali RA; Hilmi IN
    Indian J Gastroenterol; 2020 Jun; 39(3):261-267. PubMed ID: 32613522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients.
    Chaparro M; Barreiro-de Acosta M; Echarri A; Almendros R; Barrio J; Llao J; Gomollón F; Vera M; Cabriada JL; Guardiola J; Guerra I; Beltrán B; Roncero O; Busquets D; Taxonera C; Calvet X; Ferreiro-Iglesias R; Ollero Pena V; Bernardo D; Donday MG; Garre A; Godino A; Díaz A; Gisbert JP
    Dig Dis Sci; 2019 Mar; 64(3):846-854. PubMed ID: 30426297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Association of Inflammatory Bowel Diseases with Autoimmune Disorders: A Report from the epi-IIRN.
    Bar Yehuda S; Axlerod R; Toker O; Zigman N; Goren I; Mourad V; Lederman N; Cohen N; Matz E; Dushnitzky D; Gavish M; Borovsky N; Schwarts D; Dotan I; Turner D
    J Crohns Colitis; 2019 Mar; 13(3):324-329. PubMed ID: 30304371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.